𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thalidomide for the Treatment of Refractory Multiple Myeloma: Association of Plasma Concentrations of Thalidomide and Angiogenic Growth Factors with Clinical Outcome

✍ Scribed by Kakimoto, Tsunayuki ;Hattori, Yutaka ;Okamoto, Shinichiro ;Sato, Norihide ;Kamata, Tamihiro ;Yamaguchi, Masaya ;Morita, Kunihiko ;Yamada, Taketo ;Takayama, Nobuyuki ;Uchida, Hideo ;Shimada, Naoki ;Tanigawara, Yusuke ;Ikeda, Yasuo


Book ID
108582183
Publisher
Wiley (Blackwell Publishing)
Year
2002
Tongue
English
Weight
139 KB
Volume
93
Category
Article
ISSN
0910-5050

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The combination of intermediate doses of
✍ E. Hatjiharissi; E. Terpos; M. Papaioannou; C. Hatjileontis; V. Kaloutsi; G. Gal πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 288 KB

## Abstract The aim of the study was the evaluation of anti‐angiogenic activity of the combination of intermediate doses of thalidomide and dexamethasone in patients with refractory/relapsed myeloma. Twenty‐five patients were included in the study. Microvessel density (MVD) was evaluated in marrow

Extramedullary (EMP) relapse in unusual
✍ E. Katodritou; V. Gastari; E. Verrou; C. Hadjiaggelidou; M. Varthaliti; S. Georg πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 186 KB

Extramedullary relapse constitutes an uncommon manifestation of multiple myeloma (MM), characterized by highly malignant histology, special biological features, resistance to treatment and poor outcome. Its incidence has been increased during the last years, probably due to the introduction of novel